WooGene B&G Co Ltd
018620
Company Profile
Business description
WooGene B&G Co Ltd manufactures and markets medicines for animals. The company plans to start new business that manufactures raw materials of medicines for human beings, microbial pesticides and functional health food.
Contact
528-5, Songsan-Ri
Yanggam-Myeon
HwaseongGyeonggi-do445-933
KORT: +82 27952361
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
100
Stocks News & Analysis
stocks
Pure-play data center share raises capital to fund AI demand
Funding the next wave of data center growth.
stocks
Chart of the Week: BHP’s growth story faces a reality check
China’s slowing economy could weigh on BHP’s future growth.
stocks
3 best ASX growth stocks to buy for the long term
Here’s three high-quality growth companies with wide moats.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,978.80 | 34.20 | -0.38% |
| CAC 40 | 8,309.17 | 68.69 | -0.82% |
| DAX 40 | 24,717.36 | 198.13 | -0.80% |
| Dow JONES (US) | 52,552.97 | 105.67 | -0.20% |
| FTSE 100 | 10,570.37 | 1.87 | -0.02% |
| HKSE | 24,562.24 | 446.36 | -1.78% |
| NASDAQ | 25,881.95 | 387.28 | -1.47% |
| Nikkei 225 | 64,141.12 | 2,694.42 | -4.03% |
| NZX 50 Index | 13,694.68 | 79.90 | 0.59% |
| S&P 500 | 7,533.77 | 38.63 | -0.51% |
| S&P/ASX 200 | 8,796.70 | 20.10 | -0.23% |
| SSE Composite Index | 3,764.15 | 118.26 | -3.05% |